| P50 | author | Elsa Bronze-Da-Rocha | Q74445759 |
| P2093 | author name string | Elsa Bronze-da-Rocha | |
| P2860 | cites work | Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction | Q37473142 |
| | MicroRNAs and cardiac pathology | Q37478072 |
| | Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction | Q37662409 |
| | Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production | Q37769424 |
| | Induction of microRNA-24 by HIF-1 protects against ischemic injury in rat cardiomyocytes | Q85272585 |
| | Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction | Q85950682 |
| | Intronic microRNA (miRNA) | Q21284464 |
| | The nuclear RNase III Drosha initiates microRNA processing | Q24295234 |
| | Clustering and conservation patterns of human microRNAs | Q24524119 |
| | miRBase: microRNA sequences, targets and gene nomenclature | Q24538656 |
| | A uniform system for microRNA annotation | Q24540187 |
| | MicroRNA genes are transcribed by RNA polymerase II | Q24562649 |
| | miR-126 regulates angiogenic signaling and vascular integrity | Q24569770 |
| | Modulation of microRNA processing and expression through RNA editing by ADAR deaminases | Q24594425 |
| | The microRNA Registry | Q24600787 |
| | Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 |
| | MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease | Q24608809 |
| | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| | MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction | Q24648242 |
| | MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes | Q24650009 |
| | Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 |
| | Mammalian mirtron genes | Q24652239 |
| | Frequency and fate of microRNA editing in human brain | Q24653250 |
| | The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis | Q24656947 |
| | A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 |
| | Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? | Q26992023 |
| | MicroRNAs as biomarkers for myocardial infarction | Q27000432 |
| | Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks | Q37448085 |
| | Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. | Q51006594 |
| | Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. | Q51488807 |
| | Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. | Q51645450 |
| | MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction | Q51652483 |
| | MicroRNA in erythrocytes. | Q53348496 |
| | Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. | Q53510675 |
| | A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. | Q54226923 |
| | Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients. | Q54269779 |
| | Serum levels of microRNAs in patients with heart failure. | Q54336789 |
| | Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. | Q54356342 |
| | Assessment of plasma miRNAs in congestive heart failure. | Q54397399 |
| | Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 |
| | Circulating microRNAs in patients with coronary artery disease. | Q54421687 |
| | MiR423-5p as a circulating biomarker for heart failure. | Q54439825 |
| | Pathogenesis and pathophysiology of aortic valve stenosis in adults. | Q55055289 |
| | A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction | Q57256865 |
| | microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation | Q57395334 |
| | Circulating microRNAs: novel biomarkers for cardiovascular diseases? | Q58816149 |
| | MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients | Q61387983 |
| | Epigenetics and aging | Q61758392 |
| | Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain | Q62128946 |
| | Altered microRNA expression in human heart disease | Q80825508 |
| | Use of circulating microRNAs to diagnose acute myocardial infarction | Q83262798 |
| | Plasma microRNA 499 as a biomarker of acute myocardial infarction | Q84068842 |
| | Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples | Q84435715 |
| | Circulating microRNAs are promising novel biomarkers of acute myocardial infarction | Q84864383 |
| | Epigenetic regulation of aging. | Q37793425 |
| | Desperately seeking microRNA targets | Q37798161 |
| | MicroRNAs in development and disease | Q37899669 |
| | Circulating microRNAs: novel biomarkers for cardiovascular diseases | Q37967181 |
| | Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 |
| | Developing microRNA therapeutics | Q37981141 |
| | Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases | Q38040050 |
| | Genetics of longevity in model organisms: debates and paradigm shifts | Q38063298 |
| | MicroRNAs: new players in heart failure | Q38067639 |
| | Potential therapeutic role of microRNAs in ischemic heart disease. | Q38089400 |
| | The microRNA regulation of stem cells | Q38117120 |
| | microRNA therapeutics in cardiovascular disease models. | Q38151144 |
| | Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication | Q38165939 |
| | Transcoronary concentration gradients of circulating microRNAs | Q38483478 |
| | MicroRNA 210 as a biomarker for congestive heart failure | Q39213469 |
| | Gene silencing in vitro and in vivo using intronic microRNAs | Q39272584 |
| | Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy | Q39957507 |
| | Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation | Q40354595 |
| | Identification of novel microRNAs negatively regulating cardiac hypertrophy | Q41166487 |
| | Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 |
| | Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels | Q43044147 |
| | miRNA expression in the failing human heart: functional correlates | Q43124379 |
| | Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. | Q43584980 |
| | Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease | Q43798118 |
| | Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients | Q43819448 |
| | Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. | Q44134695 |
| | Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease | Q44634303 |
| | Refining diagnostic microRNA signatures by whole-miRNome kinetic analysis in acute myocardial infarction. | Q45959887 |
| | miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. | Q46415244 |
| | The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage | Q46491561 |
| | Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity | Q47037320 |
| | MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction | Q48101030 |
| | Aging-associated cardiovascular changes and their relationship to heart failure | Q27024178 |
| | Combinatorial microRNA target predictions | Q27860510 |
| | The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes | Q28115751 |
| | The hallmarks of aging | Q28131641 |
| | Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 |
| | Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction | Q28264011 |
| | MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction | Q28268501 |
| | A translational study of circulating cell-free microRNA-1 in acute myocardial infarction | Q28275588 |
| | Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction | Q28278894 |
| | MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination | Q28283112 |
| | microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles | Q28387168 |
| | miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells | Q28473023 |
| | mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts | Q28594889 |
| | Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624* | Q28743899 |
| | The genetics of ageing | Q29547430 |
| | Treatment of HCV infection by targeting microRNA | Q29547712 |
| | Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 |
| | Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 |
| | MicroRNA-133 controls cardiac hypertrophy | Q29616572 |
| | Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection | Q29618076 |
| | RNA polymerase III transcribes human microRNAs | Q29618698 |
| | MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure | Q29619548 |
| | Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR | Q29619777 |
| | Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction? | Q33573959 |
| | Non-coding RNAs: a key to future personalized molecular therapy? | Q33762263 |
| | Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. | Q33997657 |
| | Gene expression profiling in whole blood of patients with coronary artery disease | Q34070557 |
| | MicroRNA assassins: factors that regulate the disappearance of miRNAs. | Q34091173 |
| | The peripheral blood mononuclear cell microRNA signature of coronary artery disease | Q34104103 |
| | Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans | Q34141257 |
| | Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage | Q34189929 |
| | Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. | Q34242118 |
| | Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? | Q34455538 |
| | Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction | Q34510584 |
| | Evaluation of the acutely dyspneic elderly patient | Q34623237 |
| | MicroRNAs in normal and malignant hematopoiesis | Q34785149 |
| | Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease | Q34976122 |
| | Plasma miR-208 as a biomarker of myocardial injury | Q34998594 |
| | microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. | Q35006058 |
| | microRNA: emerging therapeutic targets in acute ischemic diseases | Q35011762 |
| | Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease | Q35039895 |
| | Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina | Q35048954 |
| | Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease | Q35049811 |
| | Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease | Q35067334 |
| | MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. | Q35110023 |
| | Extracellular microRNA: a new source of biomarkers | Q35417685 |
| | The biogenesis and characterization of mammalian microRNAs of mirtron origin. | Q35633635 |
| | Microparticles: major transport vehicles for distinct microRNAs in circulation | Q35792749 |
| | MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. | Q35858066 |
| | The intersection between aging and cardiovascular disease | Q36006533 |
| | Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction | Q36025533 |
| | Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy | Q36194321 |
| | Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction | Q36503183 |
| | Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction | Q36555021 |
| | MicroRNAs in age-related diseases | Q36602107 |
| | Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. | Q36688493 |
| | MicroRNA-21 in cardiovascular disease | Q36727758 |
| | MicroRNAs and the genetic network in aging. | Q36955062 |
| | Emerging role of microRNAs in cardiovascular biology. | Q37026583 |
| | MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress | Q37038566 |
| | Getting to the root of miRNA-mediated gene silencing | Q37055551 |
| | MicroRNAs: novel regulators in cardiac development and disease | Q37176880 |
| | Aging and disease as modifiers of efficacy of cell therapy | Q37183949 |
| | Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis. | Q37310442 |
| | MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 |
| | Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. | Q37358790 |
| | Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Q37360422 |
| | Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy | Q37387253 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| | coronary artery disease | Q844935 |
| | myocardial infarction | Q12152 |
| | microRNA | Q310899 |
| | cardiovascular disease | Q389735 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 985408 | |
| P577 | publication date | 2014-06-12 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | MicroRNAs expression profiles in cardiovascular diseases | |
| P478 | volume | 2014 | |